Effectiveness and Optimal Duration of Adjunctive Rifampin Treatment in the Management of <i>Staphylococcus aureus</i> Prosthetic Joint Infections After Debridement, Antibiotics, and Implant Retention

Abstract

This study supports current guidelines that recommend adjunctive rifampin use for up to 6 months among patients with <i>S aureus</i> PJI treated with DAIR.